<div id="readability-page-1">Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends.</div>

513700

00460

513120

<p>Hong Kong's innovative drug sector is experiencing significant growth, with companies like Ascletis Pharmaincreasing over 3% and Hansoh Pharmaceuticalrising by more than 2%. Other firms, including WuXi AppTecand Sihuan Pharmaceutical, are also showing upward trends.</p>

CoinLive

Penghua CSI HK Connect Health Care Composite ETF

SIHUAN PHARM

GF CSI HK Innovative Drugs Industry ETF(QDII)

China Universal CNI HK Connect Innovative Drugs Industry ETF

Hwabao WP Hang Seng SCHK Innovative Drug Select ETF

HANSOH PHARMA

E Fund Hang Seng SCHK Innovative Drug ETF

Huatai-PB Hang Seng Innovative Drugs Industry ETF(QDII)

Bosera Hang Seng SCHK Innovative Drug Select ETF

ASCLETIS-B

WUXI APPTEC

Hong Kong's Innovative Drug Sector Gains Momentum